Rheumatology 2003; 42: 276-279
© 2003 British Society for Rheumatology
Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus
University of Birmingham and
1 City Hospital NHS Trust, Birmingham, UK and
2 Putrajaya Hospital, Malaysia
Objective. To determine if there is any association between autoantibody profile and damage in a cohort of patients with systemic lupus erythematosus (SLE).
Methods. A prospective cohort of SLE patients attending two SLE clinics in Birmingham was analysed. All patients fulfilled ARA criteria for SLE. Detailed clinical and serological information was recorded at each visit. Damage according to the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI) was recorded 6-monthly and the last score in the year 2000 or prior to death was used in the analysis. Univariate analysis was performed with the 
2 test, Fisher's exact test or univariate analysis of variance. Multivariate analysis was done with binary logistic regression.
Results. A total of 348 patients (326 females) were studied, comprising 208 Caucasians, 65 Afro-Caribbeans, 59 Asians, four Orientals and 12 others. There were 32 (9.2%) deaths and 156 (44.8%) patients had damage recorded during follow-up. The presence of damage showed no significant association with race, sex or anti-cardiolipin, anti-Ro, anti-La, anti-Sm, anti-RNP and anti-dsDNA antibodies. Only age, disease duration and other antibodies to extractable nuclear antigens (ENA) were found to be associated with the presence of damage. When individual organ damage was analysed, the only significant associations were of anti-Ro with ocular damage and of other anti-ENA antibodies (anti-Scl-70 and/or anti-Jo-1) with premature gonadal failure. Other autoantibodies were not predictive of damage in individual organs.
Conclusions. Although autoantibodies are useful in diagnosis and predicting disease activity in SLE, they do not appear to be useful in predicting damage in SLE.
Correspondence to: C. Gordon, Department of Rheumatology, The Medical School, University of Birmingham, Birmingham B15 2TT, UK. E-mail: p.c.gordon{at}bham.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Descloux, I. Durieu, P. Cochat, D. Vital-Durand, J. Ninet, N. Fabien, and R. Cimaz Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus Rheumatology, July 1, 2009; 48(7): 779 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. PESCHKEN, S. J. KATZ, E. SILVERMAN, J. E. POPE, P. R. FORTIN, C. PINEAU, C. D. SMITH, H. O. ARBILLAGA, D. D. GLADMAN, M. UROWITZ, et al. The 1000 Canadian Faces of Lupus: Determinants of Disease Outcome in a Large Multiethnic Cohort J Rheumatol, June 1, 2009; 36(6): 1200 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Bertoli, L. M. Vila, M. Apte, B. J. Fessler, H. M. Bastian, J. D. Reveille, G. S. Alarcon, and for the LUMINA Study Group Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: Anaemia as a predictor of disease activity and damage accrual Rheumatology, September 1, 2007; 46(9): 1471 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Isenberg, J. J. Manson, M. R. Ehrenstein, and A. Rahman Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology, July 1, 2007; 46(7): 1052 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage Lupus, June 1, 2007; 16(6): 410 - 417. [Abstract] [PDF]
|
|
|
|
|
|
L M Vila, M J Molina, A M Mayor, R A Peredo, M L Santaella, and S Vila Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus Lupus, December 1, 2006; 15(12): 892 - 898. [Abstract] [PDF]
|
|
|
|
|
|
P. D. Ziakas, U. G. Dafni, S. Giannouli, A. G. Tzioufas, and M. Voulgarelis Thrombocytopaenia in lupus as a marker of adverse outcome--seeking Ariadne's thread Rheumatology, October 1, 2006; 45(10): 1261 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Prasad, D Ibanez, D Gladman, and M Urowitz Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus, May 1, 2006; 15(5): 285 - 291. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Mikdashi, A. Krumholz, and B. Handwerger Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus Neurology, June 28, 2005; 64(12): 2102 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M W Beresford, A G Cleary, J A Sills, J Couriel, and J E Davidson Cardio-pulmonary involvement in juvenile systemic lupus erythematosus Lupus, February 1, 2005; 14(2): 152 - 158. [Abstract] [PDF]
|
|
|
|
|
|
G Ruiz-Irastorza, M-V Egurbide, A Martinez-Berriotxoa, J Ugalde, and C Aguirre Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus Lupus, December 1, 2004; 13(12): 900 - 905. [Abstract] [PDF]
|
|
|
|
|
|
J. Mikdashi and B. Handwerger Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort Rheumatology, December 1, 2004; 43(12): 1555 - 1560. [Abstract] [Full Text] [PDF]
|
|